Marksans Pharma Complete Financial Statements
MARKSANS • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Marksans Pharma (MARKSANS).
Downloads include all available records across all periods.
For market performance, see the
MARKSANS stock price today
.
Profitability Ratios
Net Profit Margin
13.34%
2025 data
EBITDA Margin
22.37%
2025 data
Operating Margin
20.00%
2025 data
Return on Assets
3.06%
2025 data
Return on Equity
3.98%
2025 data
Balance Sheet Ratios
Current Ratio
8.07
2025 data
Debt to Equity
1.30
2025 data
Equity Ratio
76.82%
2025 data
Asset Turnover
0.23
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+15.6%
Year-over-Year
Net Profit Growth
+1.0%
Year-over-Year
EBITDA Growth
+12.9%
Year-over-Year
Expense Growth
+16.4%
Year-over-Year
Assets Growth
+20.9%
Year-over-Year
Equity Growth
+19.3%
Year-over-Year
Liabilities Growth
+20.9%
Year-over-Year
Operating Cash Flow Growth
-10.0%
Year-over-Year
Investing Cash Flow Growth
+65.2%
Year-over-Year
Financing Cash Flow Growth
+5.8%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Mar 2018 | Jun 2018 | Dec 2018 | Sept 2017 | Mar 2017 | Jun 2017 | Dec 2017 | Sept 2016 | Mar 2016 | Jun 2016 | Dec 2016 | Sept 2015 | Mar 2015 | Jun 2015 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 742 | 724 | 626 | 642 | 577 | 606 | 710 | 550 | 497 | 510 | 591 | 467 | 433 | 450 | 498 | 370 | 336 | 355 | 375 | 360 | 335 | 331 | 355 | 264 | 257 | 247 | 288 | 268 | 199 | 239 | 249 | 274 | 192 | 221 | 219 | 187 | 210 | 187 | 215 | 256 | 171 | 210 | 217 |
| Expenses | 576 | 582 | 520 | 495 | 450 | 462 | 543 | 417 | 376 | 398 | 453 | 372 | 354 | 361 | 403 | 301 | 235 | 272 | 305 | 273 | 266 | 261 | 267 | 223 | 232 | 213 | 240 | 232 | 195 | 200 | 212 | 249 | 177 | 192 | 190 | 180 | 206 | 173 | 188 | 204 | 132 | 160 | 187 |
| EBITDA | 166 | 142 | 106 | 147 | 126 | 143 | 167 | 133 | 121 | 112 | 138 | 94 | 79 | 89 | 94 | 69 | 101 | 83 | 70 | 87 | 69 | 70 | 88 | 41 | 25 | 35 | 47 | 36 | 4 | 39 | 36 | 25 | 15 | 29 | 29 | 7 | 4 | 14 | 27 | 51 | 39 | 50 | 31 |
| Operating Profit Margin % | 20.00% | 18.00% | 16.00% | 23.00% | 20.00% | 22.00% | 20.00% | 21.00% | 23.00% | 20.00% | 23.00% | 18.00% | 15.00% | 17.00% | 16.00% | 17.00% | 29.00% | 22.00% | 16.00% | 23.00% | 21.00% | 21.00% | 25.00% | 13.00% | 6.00% | 13.00% | 16.00% | 14.00% | 2.00% | 15.00% | 15.00% | 9.00% | 4.00% | 13.00% | 13.00% | 0.00% | 2.00% | 7.00% | 12.00% | 20.00% | 23.00% | 24.00% | 14.00% |
| Depreciation | 27 | 23 | 23 | 20 | 21 | 20 | 21 | 18 | 14 | 14 | 22 | 14 | 21 | 11 | 13 | 7 | 1 | 8 | 9 | 19 | 10 | 7 | 9 | 5 | 6 | 5 | 7 | 6 | 6 | 6 | 5 | 7 | 8 | 7 | 6 | 6 | 8 | 5 | 12 | 6 | 4 | 5 | 10 |
| Interest | 6 | 3 | 6 | 3 | 5 | 3 | 3 | 2 | 2 | 2 | 3 | 3 | 5 | 2 | 2 | 2 | 3 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 3 | 4 | 2 | 2 | 3 | 2 | 2 | 2 | 1 | 2 | 1 | 2 | 3 | 1 | 3 | 2 |
| Profit Before Tax | 133 | 116 | 77 | 125 | 100 | 120 | 143 | 114 | 104 | 97 | 113 | 78 | 53 | 76 | 79 | 60 | 97 | 75 | 60 | 66 | 58 | 61 | 78 | 34 | 17 | 28 | 38 | 28 | -6 | 30 | 30 | 15 | -1 | 20 | 21 | 0 | 0 | 7 | 13 | 43 | 36 | 45 | 19 |
| Tax | 34 | 25 | 18 | 27 | 23 | 31 | 38 | 30 | 22 | 26 | 30 | 18 | 23 | 16 | 17 | 14 | 18 | 12 | 12 | 15 | 15 | 12 | 19 | 8 | 7 | 5 | 9 | 7 | 1 | 6 | 4 | 4 | 2 | 5 | 4 | -1 | 4 | 2 | 2 | 7 | 10 | 13 | 0 |
| Net Profit | 99 | 91 | 58 | 98 | 78 | 89 | 105 | 84 | 83 | 70 | 83 | 60 | 30 | 60 | 62 | 46 | 80 | 63 | 48 | 51 | 43 | 49 | 59 | 26 | 10 | 23 | 30 | 21 | -7 | 25 | 25 | 10 | -3 | 14 | 18 | 1 | -4 | 5 | 12 | 36 | 26 | 32 | 19 |
| Earnings Per Share (₹) | 2.17 | 2.00 | 1.29 | 2.13 | 1.73 | 1.96 | 2.31 | 1.84 | 1.97 | 1.52 | 1.84 | 1.52 | 0.69 | 1.46 | 1.56 | 1.11 | 1.93 | 1.51 | 1.20 | 1.21 | 1.00 | 1.20 | 1.42 | 0.63 | 0.21 | 0.52 | 0.71 | 0.48 | -0.17 | 0.58 | 0.60 | 0.23 | 0.00 | 0.33 | 0.41 | 0.02 | -0.14 | 0.11 | 0.24 | 0.85 | 0.61 | 0.77 | 0.44 |
Related Pages for Marksans Pharma
Additional stock information and data for MARKSANS
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 3,240 | 2,681 | 2,190 | 1,640 | 1,229 | 903 | 804 | 729 | 752 | 722 | 676 |
| Current Assets | 2,204 | 1,863 | 1,675 | 1,201 | 903 | 594 | 531 | 449 | 484 | 440 | 509 |
| Fixed Assets | 982 | 776 | 486 | 428 | 309 | 303 | 270 | 279 | 267 | 270 | 166 |
| Capital Work in Progress | 27 | 9 | 10 | 3 | 12 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 1 | 27 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 2,230 | 1,869 | 1,694 | 1,209 | 908 | 600 | 534 | 450 | 485 | 453 | 510 |
| LIABILITIES | |||||||||||
| Total Liabilities | 3,240 | 2,681 | 2,190 | 1,640 | 1,229 | 903 | 804 | 729 | 752 | 722 | 676 |
| Current Liabilities | 273 | 205 | 84 | 61 | 25 | 25 | 18 | 16 | 16 | 0 | 2 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 2,489 | 2,086 | 1,765 | 1,223 | 905 | 649 | 553 | 480 | 440 | 463 | 388 |
| Share Capital | 45 | 45 | 45 | 41 | 41 | 41 | 41 | 41 | 41 | 53 | 53 |
| Reserves & Surplus | 2,422 | 2,020 | 1,700 | 1,068 | 846 | 595 | 502 | 430 | 393 | 401 | 326 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 207 | 230 | 237 | 99 | 179 | 233 | 27 | 50 | 14 | 31 | 155 |
| Investing Activities | -49 | -141 | -259 | -84 | -45 | -60 | -14 | -39 | -21 | -123 | -33 |
| Financing Activities | -65 | -69 | 198 | 80 | -15 | -114 | -21 | 3 | -4 | -58 | 17 |
| Net Cash Flow | 93 | 21 | 176 | 94 | 119 | 60 | -7 | 15 | -10 | -150 | 138 |